REGENXBIO
RGNX
#7519
Rank
A$0.71 B
Marketcap
A$10.82
Share price
-0.28%
Change (1 day)
-40.80%
Change (1 year)

EPS for REGENXBIO (RGNX)

EPS in 2026 (TTM): A-$4.70

According to REGENXBIO's latest financial reports the company's current EPS (TTM) is A-$4.85. In 2025 the company made an earnings per share (EPS) of A-$5.68 an increase over its 2024 EPS that were of A-$6.96.

EPS history for REGENXBIO from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$4.70-17.32%
2025A-$5.68-18.44%
2024A-$6.96
2022A-$9.82-321.09%
2021A$4.44-198.33%
2020A-$4.5215.44%
2019A-$3.91-181.19%
2018A$4.82-229.15%
2017A-$3.733.35%
2016A-$3.615.42%
2015A-$3.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
A-$2.04-57.94%๐Ÿ‡บ๐Ÿ‡ธ USA